We found agreement between all samples in which a SARS-CoV-2-infection was identified via the detection of NCP-, RBD- and/or SP1-IgG in the Mikrogen® recomLine blot and those in which an infection was identified via the detection of IgG to SP1 in the Roche® ECLIA. This evidence concerns the gene SP1 and infection.